Abstract:Abstract Adequate vitamin D and calcium supplementation therapy in osteoporosis reduces the risk of fragility fractures and correlates with improved mortality outcomes in postoperative fragility hip fracture patients. However, the prevalence of adequate supplementation in this population remains unclear. Our purpose was to describe supplement use among the adult population in United States who have been told they had osteoporosis and identify factors associated with adequate supplementation, particularly in patients with history of hip fracture. The study sample comprised a total of 15,968 respondents from the National Health and Examinations Survey (NHANES 2007–2010, 2013–2014); 1,065 self-reported a diagnosis of osteoporosis and 266 self-reported a history of hip fracture. Additional patient factors were analyzed by multivariable logistic regression to assess associated factors of adequate vitamin D (≥ 600 international unit [IU]/day) and calcium (≥ 1000 mg/day) supplementation. The prevalence of vitamin D and calcium supplementation was significantly higher in the osteoporosis group than without (p = 0.001). However, supplemental intake reached adequate levels (≥ 600 IU/day of vitamin D and ≥ 1000mg/day of calcium) in only 28.8% of individuals with osteoporosis for vitamin D, 51.6% for calcium, and 19.2% for both. Of individuals with additional history of hip fracture, only 14% reported adequate intake of both nutrients. Female sex (odds ratio [OR]: 2.35, p < 0.001), older age (OR: 1.02, p < 0.001), and Caucasian race (OR: 1.456, p = 0.004) were positive factors of adequate supplementation, while Hispanic ethnicity was a negative factor (OR: 0.658, p = 0.009). Unexpectedly, a history of hip fracture did not affect the odds of adequate treatment (OR: 0.685, p = 0.176). Adults with known osteoporosis in the United States are self-reporting inadequate supplementation therapy, and significant gender and racial disparities exist. There is a broad need for improved supplementation to help manage this disease, particularly among adults with prior hip fracture, a vulnerable population most relevant for orthopaedic surgeons. This study serves as a call-to-action for orthopaedic surgeons to ensure their fragility hip fracture patients receive adequate supplementation postoperatively to maximize their health and recovery. This was a Level III, retrospective cohort study.

Estrogen Replacement Therapy and Fractures in Older Women

Estrogen therapy for geriatric osteoporosis: just one ball in a complex juggling act

Physical Activity and Osteoporotic Fracture Risk in Older Women

Risk of Subsequent Fractures and Mortality in Elderly Women and Men with Fragility Fractures with and without Osteoporotic Bone Density: The Dubbo Osteoporosis Epidemiology Study

Postmenopausal estrogen therapy and depressive symptoms in older women

Hormone replacement therapy and hip fracture risk: effect modification by tobacco smoking, alcohol intake, physical activity, and body mass index

Estrogen and bones after menopause: a reappraisal of data and future perspectives

Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative

Endogenous Hormones, Muscle Strength, and Risk of Fall-Related Fractures in Older Women.

Exercise and fractures in postmenopausal women. Final results of the controlled Erlangen Fitness and Osteoporosis Prevention Study (EFOPS)

Physical Functioning among Women Aged 80 Years and Older with Previous Fracture

Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group

Estrogen therapy for osteoporosis in the modern era

Estimating Bisphosphonate Use And Fracture Reduction Among Us Women Aged 45 Years And Older, 2001-2008

Anti-fracture treatment efficacy by age

Calcium and Vitamin D Supplementation in Osteoporosis and Fragility Hip Fracture Patients: A Retrospective NHANES Study

[Estrogen replacement therapy: for whom, why and how?]

The use of estrogen in older women

Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study

The Use of Antiestrogens in the Postmenopausal Woman

An economic analysis of hormone replacement therapy for the prevention of fracture in young postmenopausal women